Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer

Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer

Abstract Background Chemoradiotherapy (CRT) is the standard treatment for patients with inoperable stage III non‐small cell lung cancer (NSCLC) stage III. With a median OS beyond 30 months, adequate pulmonary function (PF) is essential to ensure acceptable quality of life after treatment. Forced exp...

Full description

Bibliographic Details
Main Authors: Brane Grambozov, Frank Wolf, Julia Kaiser, Romana Wass, Gerd Fastner, Christoph Gaisberger, Lukas Rettenbacher, Michael Studnicka, Christian Pirich, Felix Sedlmayer, Franz Zehentmayr
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Thoracic Cancer
Subjects:
DLCO
FEV1
minimal clinically important difference (MCID)
NSCLC
radiotherapy
Online Access:https://doi.org/10.1111/1759-7714.13276

Internet

https://doi.org/10.1111/1759-7714.13276

Similar Items